MaRS Centre, 661 University Avenue, Suite 480
Toronto, Ontario, Canada, M5G 1M1
Pipeline
Our AI workbench is enabling the discovery of novel therapeutic targets for diseases with high unmet need.
| THERAPEUTIC AREA | TARGET VALIDATION | DISCOVERY | PRECLINICAL | CLINICAL | PARTNER |
|---|---|---|---|---|---|
| CNS | |||||
| Frontotemporal Dementia |
|
||||
| Niemann-Pick Disease Type C |
|
||||
| Pediatric Epilepsy |
|
||||
| Parkinson's Disease |
|
||||
| Metabolic | |||||
| Wilson Disease |
|
||||
| Refractory Gout |
|
||||
| Partnered | |||||
| Undisclosed |
|
|
|||
| Undisclosed |
|
|
|||
| Undisclosed |
|
|
|||
| Undisclosed |
|
|
|||
| Target Identification | |||||
| Under Assessment (N=20) |
|
||||
© 2021 DEEP GENOMICS. ALL RIGHTS RESERVED.